{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:40Z","timestamp":1787020840885,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010909","name":"Young Scientists Fund","doi-asserted-by":"publisher","award":["81802316"],"award-info":[{"award-number":["81802316"]}],"id":[{"id":"10.13039\/501100010909","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010909","name":"Young Scientists Fund","doi-asserted-by":"publisher","award":["81903049"],"award-info":[{"award-number":["81903049"]}],"id":[{"id":"10.13039\/501100010909","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010905","name":"Major Research Plan","doi-asserted-by":"publisher","award":["82173219"],"award-info":[{"award-number":["82173219"]}],"id":[{"id":"10.13039\/501100010905","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tumor cells exhibited phenotypic and molecular characteristics similar to their lineage progenitor cells. Liver developmental signaling pathways are showed to be associated with HCC development and oncogenesis. The similarities of expression profiling between liver progenitors (LPs) and HCC suggest that understanding the molecular mechanism during liver development could provide insights into HCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      To profile the dynamic gene expression during liver development, cells from an in vitro liver differentiation model and two paired hepatocellular carcinoma (HCC) samples were analyzed using deep RNA sequencing. The expression levels of selected genes were analyzed by qRT-PCR. Moreover, the role of a key transcription factor, pituitary homeobox\u00a02 (\n                      <jats:italic>PITX2<\/jats:italic>\n                      ), was characterized via in vitro and\n                      <jats:italic>vivo<\/jats:italic>\n                      functional assays. Furthermore, molecular mechanism studies were performed to unveil how\n                      <jats:italic>PITX2C<\/jats:italic>\n                      regulate the key developmental factors in LPs, thereby increasing the stemness of HCC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>PITX2<\/jats:italic>\n                      was found to exhibit a similar expression pattern to specific markers of LPs.\n                      <jats:italic>PITX2<\/jats:italic>\n                      consists of three isoforms (\n                      <jats:italic>PITX2A\/B\/C<\/jats:italic>\n                      ). The expression of\n                      <jats:italic>PITX2<\/jats:italic>\n                      is associated with tumor size and overall survival rate, whereas only\n                      <jats:italic>PITX2C<\/jats:italic>\n                      expression is associated with AFP and differentiation in clinical patients. PITX2A\/B\/C has distinct functions in HCC tumorigenicity. PITX2C promotes HCC metastasis, self-renewal and chemoresistance. Molecular mechanism studies showed that PITX2C could up-regulate RALYL which could enhance HCC stemness via the TGF-\u03b2 pathway. Furthermore, ChIP assays confirmed the role of PITX2C in regulating key developmental factors in LP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PITX2C is a newly discovered transcription factor involved in hepatic differentiation and could increase HCC stemness by upregulating key transcriptional factors related to liver development.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-022-02424-z","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T03:05:38Z","timestamp":1656385538000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["PITX2C increases the stemness features of hepatocellular carcinoma cells by up-regulating key developmental factors in liver progenitor"],"prefix":"10.1186","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6037-6972","authenticated-orcid":false,"given":"Lingxi","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minmin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoran","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-yuan","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"issue":"2","key":"2424_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332 PubMed PMID: 26808342. Epub 2016\/01\/26. eng.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"2424_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nm1377","volume":"12","author":"JS Lee","year":"2006","unstructured":"Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med. 2006;12(4):410\u20136 PubMed PMID: 16532004.","journal-title":"Nat Med"},{"issue":"1","key":"2424_CR3","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/hep.22704","volume":"49","author":"L Mishra","year":"2009","unstructured":"Mishra L, Banker T, Murray J, Byers S, Thenappan A, He AR, et al. Liver stem cells and hepatocellular carcinoma. Hepatology. 2009;49(1):318\u201329 PubMed PMID: 19111019. Pubmed Central PMCID: 2726720.","journal-title":"Hepatology."},{"key":"2424_CR4","doi-asserted-by":"crossref","unstructured":"Zorn AM. Liver development. Cambridge: IOS Press; 2008.","DOI":"10.3824\/stembook.1.25.1"},{"issue":"2","key":"2424_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4161\/cc.5.2.2341","volume":"5","author":"F Clotman","year":"2006","unstructured":"Clotman F, Lemaigre FP. Control of hepatic differentiation by activin\/TGFbeta signaling. Cell Cycle. 2006;5(2):168\u201371 PubMed PMID: 16357531.","journal-title":"Cell Cycle"},{"issue":"1","key":"2424_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.yexcr.2003.08.020","volume":"292","author":"SZ Hussain","year":"2004","unstructured":"Hussain SZ, Sneddon T, Tan X, Micsenyi A, Michalopoulos GK, Monga SP. Wnt impacts growth and differentiation in ex vivo liver development. Exp Cell Res. 2004;292(1):157\u201369 PubMed PMID: 14720515.","journal-title":"Exp Cell Res"},{"issue":"2","key":"2424_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41575-018-0075-9","volume":"16","author":"MJ Perugorria","year":"2019","unstructured":"Perugorria MJ, Olaizola P, Labiano I, Esparza-Baquer A, Marzioni M, Marin JJG, et al. Wnt-beta-catenin signalling in liver development, health and disease. Nat Rev Gastroenterol Hepatol. 2019;16(2):121\u201336 PubMed PMID: 30451972.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"2424_CR8","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.molmed.2019.06.007","volume":"25","author":"J Chen","year":"2019","unstructured":"Chen J, Gingold JA, Su X. Immunomodulatory TGF-beta signaling in hepatocellular carcinoma. Trends Mol Med. 2019;25(11):1010\u201323 PubMed PMID: 31353124.","journal-title":"Trends Mol Med"},{"key":"2424_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canlet.2017.01.037","volume":"392","author":"A Malfettone","year":"2017","unstructured":"Malfettone A, Soukupova J, Bertran E, Crosas-Molist E, Lastra R, Fernando J, et al. Transforming growth factor-beta-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma. Cancer Lett. 2017;392:39\u201350 PubMed PMID: 28161507.","journal-title":"Cancer Lett"},{"issue":"11","key":"2424_CR10","doi-asserted-by":"publisher","first-page":"6103","DOI":"10.1073\/pnas.1912146117","volume":"117","author":"M Liu","year":"2020","unstructured":"Liu M, Yan Q, Sun Y, Nam Y, Hu L, Loong JH, et al. A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets. Proc Natl Acad Sci U S A. 2020;117(11):6103\u201313 PubMed PMID: 32123069. Pubmed Central PMCID: 7084088.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"D1","key":"2424_CR11","first-page":"D489","volume":"48","author":"I Rodchenkov","year":"2020","unstructured":"Rodchenkov I, Babur O, Luna A, Aksoy BA, Wong JV, Fong D, et al. Pathway commons 2019 update: integration, analysis and exploration of pathway data. Nucleic Acids Res. 2020;48(D1):D489\u2013D97 PubMed PMID: 31647099. Pubmed Central PMCID: 7145667.","journal-title":"Nucleic Acids Res"},{"issue":"6750","key":"2424_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/45803","volume":"401","author":"CR Lin","year":"1999","unstructured":"Lin CR, Kioussi C, O'Connell S, Briata P, Szeto D, Liu F, et al. Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis. Nature. 1999;401(6750):279\u201382 PubMed PMID: 10499586.","journal-title":"Nature."},{"issue":"5","key":"2424_CR13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0092-8674(02)01084-X","volume":"111","author":"C Kioussi","year":"2002","unstructured":"Kioussi C, Briata P, Baek SH, Rose DW, Hamblet NS, Herman T, et al. Identification of a Wnt\/Dvl\/beta-Catenin --> Pitx2 pathway mediating cell-type-specific proliferation during development. Cell. 2002;111(5):673\u201385 PubMed PMID: 12464179.","journal-title":"Cell."},{"issue":"1","key":"2424_CR14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1074\/jbc.M708154200","volume":"283","author":"M Hayashi","year":"2008","unstructured":"Hayashi M, Maeda S, Aburatani H, Kitamura K, Miyoshi H, Miyazono K, et al. Pitx2 prevents osteoblastic transdifferentiation of myoblasts by bone morphogenetic proteins. J Biol Chem. 2008;283(1):565\u201371 PubMed PMID: 17951577.","journal-title":"J Biol Chem"},{"issue":"28","key":"2424_CR15","doi-asserted-by":"publisher","first-page":"25001","DOI":"10.1074\/jbc.M201737200","volume":"277","author":"CJ Cox","year":"2002","unstructured":"Cox CJ, Espinoza HM, McWilliams B, Chappell K, Morton L, Hjalt TA, et al. Differential regulation of gene expression by PITX2 isoforms. J Biol Chem. 2002;277(28):25001\u201310 PubMed PMID: 11948188.","journal-title":"J Biol Chem"},{"issue":"8","key":"2424_CR16","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1073\/pnas.95.8.4573","volume":"95","author":"H Arakawa","year":"1998","unstructured":"Arakawa H, Nakamura T, Zhadanov AB, Fidanza V, Yano T, Bullrich F, et al. Identification and characterization of the ARP1 gene, a target for the human acute leukemia ALL1 gene. Proc Natl Acad Sci U S A. 1998;95(8):4573\u20138 PubMed PMID: 9539779. Pubmed Central PMCID: 22531.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"2424_CR17","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1242\/dev.126.20.4643","volume":"126","author":"PJ Gage","year":"1999","unstructured":"Gage PJ, Suh H, Camper SA. Dosage requirement of Pitx2 for development of multiple organs. Development. 1999;126(20):4643\u201351 PubMed PMID: 10498698.","journal-title":"Development."},{"issue":"6","key":"2424_CR18","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.ajhg.2016.10.001","volume":"99","author":"J Ye","year":"2016","unstructured":"Ye J, Tucker NR, Weng LC, Clauss S, Lubitz SA, Ellinor PT. A functional variant associated with atrial fibrillation regulates PITX2c expression through TFAP2a. Am J Hum Genet. 2016;99(6):1281\u201391 PubMed PMID: 27866707. Pubmed Central PMCID: 5142106.","journal-title":"Am J Hum Genet"},{"issue":"31","key":"2424_CR19","doi-asserted-by":"publisher","first-page":"5036","DOI":"10.1200\/JCO.2007.14.1697","volume":"26","author":"N Harbeck","year":"2008","unstructured":"Harbeck N, Nimmrich I, Hartmann A, Ross JS, Cufer T, Grutzmann R, et al. Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients. J Clin Oncol. 2008;26(31):5036\u201342 PubMed PMID: 18711169.","journal-title":"J Clin Oncol"},{"issue":"2","key":"2424_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10585-013-9620-7","volume":"31","author":"I Vela","year":"2014","unstructured":"Vela I, Morrissey C, Zhang X, Chen S, Corey E, Strutton GM, et al. PITX2 and non-canonical Wnt pathway interaction in metastatic prostate cancer. Clin Exp Metastasis. 2014;31(2):199\u2013211 PubMed PMID: 24162257.","journal-title":"Clin Exp Metastasis"},{"issue":"5","key":"2424_CR21","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.urolonc.2011.04.010","volume":"31","author":"A Vinarskaja","year":"2013","unstructured":"Vinarskaja A, Schulz WA, Ingenwerth M, Hader C, Arsov C. Association of PITX2 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis. Urol Oncol. 2013;31(5):622\u20137 PubMed PMID: 21803613.","journal-title":"Urol Oncol"},{"issue":"10","key":"2424_CR22","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1245\/s10434-011-1653-z","volume":"18","author":"H Hirose","year":"2011","unstructured":"Hirose H, Ishii H, Mimori K, Tanaka F, Takemasa I, Mizushima T, et al. The significance of PITX2 overexpression in human colorectal cancer. Ann Surg Oncol. 2011;18(10):3005\u201312 PubMed PMID: 21479692.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"2424_CR23","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.4161\/cc.9.7.11126","volume":"9","author":"Y Huang","year":"2010","unstructured":"Huang Y, Guigon CJ, Fan J, Cheng SY, Zhu GZ. Pituitary homeobox 2 (PITX2) promotes thyroid carcinogenesis by activation of cyclin D2. Cell Cycle. 2010;9(7):1333\u201341 PubMed PMID: 20372070.","journal-title":"Cell Cycle"},{"issue":"6","key":"2424_CR24","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1074\/jbc.M112.409102","volume":"288","author":"M Basu","year":"2013","unstructured":"Basu M, Roy SS. Wnt\/beta-catenin pathway is regulated by PITX2 homeodomain protein and thus contributes to the proliferation of human ovarian adenocarcinoma cell, SKOV-3. J Biol Chem. 2013;288(6):4355\u201367 PubMed PMID: 23250740. Pubmed Central PMCID: 3567686.","journal-title":"J Biol Chem"},{"key":"2424_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12943-015-0433-y","volume":"14","author":"M Basu","year":"2015","unstructured":"Basu M, Bhattacharya R, Ray U, Mukhopadhyay S, Chatterjee U, Roy SS. Invasion of ovarian cancer cells is induced byPITX2-mediated activation of TGF-beta and Activin-a. Mol Cancer. 2015;14:162 PubMed PMID: 26298390. Pubmed Central PMCID: 4546816.","journal-title":"Mol Cancer"},{"issue":"1","key":"2424_CR26","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/s41467-021-21828-7","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, Wang J, Tsui YM, Shi C, Wang Y, Zhang X, et al. RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-beta2. Nat Commun. 2021;12(1):1518 PubMed PMID: 33750796. Pubmed Central PMCID: 7943813.","journal-title":"Nat Commun"},{"issue":"Suppl 3","key":"2424_CR27","first-page":"1203","volume":"45","author":"M Kojiro","year":"1998","unstructured":"Kojiro M. Pathology of early hepatocellular carcinoma: progression from early to advanced. Hepatogastroenterology. 1998;45(Suppl 3):1203\u20135 PubMed PMID: 9730375.","journal-title":"Hepatogastroenterology."},{"key":"2424_CR28","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1038\/s41418-020-00726-3","volume":"28","author":"Q Yan","year":"2021","unstructured":"Yan Q, Zhang Y, Fang X, Liu B, Wong TL, Gong L, et al. PGC7 promotes tumor oncogenic dedifferentiation through remodeling DNA methylation pattern for key developmental transcription factors. Cell Death Differ. 2021;28:1955\u201370 PubMed PMID: 33500560.","journal-title":"Cell Death Differ"},{"issue":"1","key":"2424_CR29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.immuni.2008.12.009","volume":"30","author":"G Wei","year":"2009","unstructured":"Wei G, Wei L, Zhu J, Zang C, Hu-Li J, Yao Z, et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity. 2009;30(1):155\u201367 PubMed PMID: 19144320. Pubmed Central PMCID: 2722509.","journal-title":"Immunity."},{"issue":"7","key":"2424_CR30","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nrd4253","volume":"13","author":"DR Pattabiraman","year":"2014","unstructured":"Pattabiraman DR, Weinberg RA. Tackling the cancer stem cells - what challenges do they pose? Nat Rev Drug Discov. 2014;13(7):497\u2013512 PubMed PMID: 24981363. Pubmed Central PMCID: 4234172.","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"2424_CR31","first-page":"1676","volume":"5","author":"TW Leung","year":"1999","unstructured":"Leung TW, Patt YZ, Lau WY, Ho SK, Yu SC, Chan AT, et al. Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma. Clin Cancer Res. 1999;5(7):1676\u201381 PubMed PMID: 10430068. Epub 1999\/08\/03. eng.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2424_CR32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1158\/1078-0432.CCR-18-0847","volume":"25","author":"L Goyal","year":"2019","unstructured":"Goyal L, Zheng H, Abrams TA, Miksad R, Bullock AJ, Allen JN, et al. A phase II and biomarker study of Sorafenib combined with modified FOLFOX in patients with advanced hepatocellular carcinoma. Clin Cancer Res. 2019;25(1):80\u20139 PubMed PMID: 30190369. Pubmed Central PMCID: 6320284.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2424_CR33","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/S1097-2765(03)00407-6","volume":"12","author":"P Briata","year":"2003","unstructured":"Briata P, Ilengo C, Corte G, Moroni C, Rosenfeld MG, Chen CY, et al. The Wnt\/beta-catenin-->Pitx2 pathway controls the turnover of Pitx2 and other unstable mRNAs. Mol Cell. 2003;12(5):1201\u201311 PubMed PMID: 14636578.","journal-title":"Mol Cell"},{"issue":"W1","key":"2424_CR34","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556\u2013W60 PubMed PMID: 31114875. Pubmed Central PMCID: 6602440.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"2424_CR35","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nrc1947","volume":"6","author":"LA Garraway","year":"2006","unstructured":"Garraway LA, Sellers WR. Lineage dependency and lineage-survival oncogenes in human cancer. Nat Rev Cancer. 2006;6(8):593\u2013602 PubMed PMID: 16862190.","journal-title":"Nat Rev Cancer"},{"issue":"10\u201311","key":"2424_CR36","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1139\/o92-130","volume":"70","author":"RN Johnston","year":"1992","unstructured":"Johnston RN, Pai SB, Pai RB. The origin of the cancer cell: oncogeny reverses phylogeny. Biochem Cell Biol. 1992;70(10\u201311):831\u20134 PubMed PMID: 1297348.","journal-title":"Biochem Cell Biol"},{"issue":"4","key":"2424_CR37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1432-0436.2006.00066.x","volume":"74","author":"A Jochheim-Richter","year":"2006","unstructured":"Jochheim-Richter A, Rudrich U, Koczan D, Hillemann T, Tewes S, Petry M, et al. Gene expression analysis identifies novel genes participating in early murine liver development and adult liver regeneration. Differentiation. 2006;74(4):167\u201373 PubMed PMID: 16683987.","journal-title":"Differentiation"},{"issue":"1","key":"2424_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/ng.722","volume":"43","author":"K Furuyama","year":"2011","unstructured":"Furuyama K, Kawaguchi Y, Akiyama H, Horiguchi M, Kodama S, Kuhara T, et al. Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet. 2011;43(1):34\u201341 PubMed PMID: 21113154.","journal-title":"Nat Genet"},{"key":"2424_CR39","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.biocel.2016.09.024","volume":"80","author":"F Chen","year":"2016","unstructured":"Chen F, Yao H, Wang M, Yu B, Liu Q, Li J, et al. Suppressing Pitx2 inhibits proliferation and promotes differentiation of iHepSCs. Int J Biochem Cell Biol. 2016;80:154\u201362.","journal-title":"Int J Biochem Cell Biol"},{"issue":"21","key":"2424_CR40","doi-asserted-by":"publisher","first-page":"7560","DOI":"10.1128\/MCB.00315-07","volume":"27","author":"M Amen","year":"2007","unstructured":"Amen M, Liu X, Vadlamudi U, Elizondo G, Diamond E, Engelhardt JF, et al. PITX2 and beta-catenin interactions regulate Lef-1 isoform expression. Mol Cell Biol. 2007;27(21):7560\u201373 PubMed PMID: 17785445. Pubmed Central PMCID: 2169058.","journal-title":"Mol Cell Biol"},{"issue":"Pt 6","key":"2424_CR41","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1242\/jcs.01706","volume":"118","author":"U Vadlamudi","year":"2005","unstructured":"Vadlamudi U, Espinoza HM, Ganga M, Martin DM, Liu X, Engelhardt JF, et al. PITX2, beta-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter. J Cell Sci. 2005;118(Pt 6):1129\u201337 PubMed PMID: 15728254.","journal-title":"J Cell Sci"},{"issue":"2","key":"2424_CR42","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.ydbio.2006.03.018","volume":"294","author":"W Cheng","year":"2006","unstructured":"Cheng W, Guo L, Zhang Z, Soo HM, Wen C, Wu W, et al. HNF factors form a network to regulate liver-enriched genes in zebrafish. Dev Biol. 2006;294(2):482\u201396 PubMed PMID: 16631158.","journal-title":"Dev Biol"},{"issue":"16","key":"2424_CR43","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1101\/gad.390906","volume":"20","author":"I Kyrmizi","year":"2006","unstructured":"Kyrmizi I, Hatzis P, Katrakili N, Tronche F, Gonzalez FJ, Talianidis I. Plasticity and expanding complexity of the hepatic transcription factor network during liver development. Genes Dev. 2006;20(16):2293\u2013305 PubMed PMID: 16912278. Pubmed Central PMCID: 1553211.","journal-title":"Genes Dev"},{"issue":"21","key":"2424_CR44","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1038\/sj.emboj.7601883","volume":"26","author":"X Qu","year":"2007","unstructured":"Qu X, Lam E, Doughman YQ, Chen Y, Chou YT, Lam M, et al. Cited2, a coactivator of HNF4alpha, is essential for liver development. EMBO J. 2007;26(21):4445\u201356 PubMed PMID: 17932483. Pubmed Central PMCID: 2063472.","journal-title":"EMBO J"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-022-02424-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-022-02424-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-022-02424-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T06:11:49Z","timestamp":1666505509000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-022-02424-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2424"],"URL":"https:\/\/doi.org\/10.1186\/s13046-022-02424-z","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,28]]},"assertion":[{"value":"7 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments conducted on animals were approved by the University of Hong Kong Committee on the Use of Live Animals in Teaching and Research (CULATR). All clinical samples used in this study were approved by the Committee for Ethical Review of Research Involving Human Subjects at the Sun Yat-Sen University Cancer Center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"211"}}